Moderna
MRNA
#1167
Rank
C$22.81 B
Marketcap
$59.28
Share price
-0.38%
Change (1 day)
-48.56%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - P/B ratio

P/B ratio as of December 2024 : 1.34

According to Moderna 's latest financial reports the company has a price-to-book ratio of 3.16166.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Moderna - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-312.74-24.15%
2022-12-313.61-50.43%
2021-12-317.28-54.9%
2020-12-3116.1188.09%
2019-12-315.6070.78%
2018-12-313.28
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.25-7.11%๐Ÿ‡บ๐Ÿ‡ธ USA
5.73 327.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0229-101.71%๐Ÿ‡บ๐Ÿ‡ธ USA
976 72,720.80%๐Ÿ‡บ๐Ÿ‡ธ USA
4.53 237.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
14.4 977.79%๐Ÿ‡บ๐Ÿ‡ธ USA
4.98 271.78%๐Ÿ‡บ๐Ÿ‡ธ USA